Results 61 to 70 of about 47,015 (158)

A roadmap for clinical trials in MASH-related compensated cirrhosis. [PDF]

Although metabolic dysfunction-associated steatohepatitis (MASH) is rapidly becoming a leading cause of cirrhosis worldwide, therapeutic options are limited and the number of clinical trials in MASH-related compensated cirrhosis is low as compared to ...
Anstee, Quentin M, Rowe, Ian A, Bataller, Ramón, Ciudin, Andreea, Tacke, Frank, Pons, Mònica, Reiberger, Thomas, Genescà, Joan, Augustin, Salvador, Schabel, Elmer, Berzigotti, Annalisa, Abraldes, Juan G, Hernández-Gea, Virginia, Rydqvist, Peter, Pericàs, Juan M, Francque, Sven, Tsochatzis, Emmanuel A   +16 more
core   +1 more source

mash

, 1963
marsh nA miserable walk...brought us to the edge of the "yellow mash," a great inland bog covered with a short jaundiced grass. [see 'maish', 'marsh', etc.]G. M.

core  

mash

, 1976
marsh n[old games] The swinging boats in Bob Cole's mash. / Molly.- Of course I know the sort you mean, / Them swinging boats I'se often seen.JAN 1976DNE-citUsed I and SupUsed I and Sup1Used Imarish, mash, mesh, mish, BOG MEADOW, BARRENS, SAVANNA ...

core  

Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy” [PDF]

Clinical and Molecular Hepatology
Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu   +3 more
doaj   +1 more source

Real-world work productivity is impaired in people with metabolic dysfunction-associated steatotic liver disease in the USA

JHEP Reports
Background & Aims: The impact of metabolic dysfunction-associated steatohepatitis (MASH) on patient-reported outcomes is poorly understood. We assessed work productivity burden in a real-world population with suspected/confirmed MASH, comparing work ...
Shraddha Shinde, Mary E. Rinella, Mark L. Hartman, David Schapiro, Victoria Higgins, Andrea Leith, James Pike, Quentin M. Anstee   +7 more
doaj   +1 more source

The Nb4C3 MXenzyme Attenuates MASH by Scavenging ROS in a Mouse Model [PDF]

Shuying He,1,* Yuerong Lv,1,* Zixian Gao,1,* Liang Peng1,2 1Department of Gastroenterology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou city, Guangdong Province, People’s ...
He S, Lv Y, Gao Z, Peng L
core  

Sexual dimorphism in hepatic PPAR alpha and CYP4a12a expression is associated with reduced development of drug-induced non-alcoholic steatohepatitis in female IL-33−/− mice

Frontiers in Medicine
Males are at higher risk for developing metabolic dysfunction-associated steatohepatitis (MASH) than females; however, mechanisms mediating sexual dimorphism in MASH development are not completely understood.
Chloe Thomas, Dolores B. Njoku, Dolores B. Njoku   +2 more
doaj   +1 more source

mash

, 1956
marsh nA marsh or bog, a fen.G. M. Story July 1956PRINTED ITEM DNE-citUsed I and SupUsed I and Sup1Not usedmarish, mash, mesh, mish, BOG MEADOW, BARRENS, SAVANNA, ~berry, ~ birch, ~ blackbird, ~ lily, ~ moss, ~ peat, ~ tea, Mash-tea, Labrador-tea ...

core  

The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective [PDF]

Clinical and Molecular Hepatology
Carlos Jose Pirola, Silvia Sookoian
doaj   +1 more source

Risk of complications in adulthood following childhood metabolic dysfunction-associated steatohepatitis based on Korean national health insurance data

Scientific Reports
The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD), which can be complicated by metabolic dysfunction-associated steatohepatitis (MASH), is increasing worldwide.
Yunkoo Kang, Yeonjae Park, Hong Koh
doaj   +1 more source